TAHO is a specialty pharma focus on identifying, and developing new products that offer better therapeutic options to patient populations that may be under served.
By utilizing company’s technology platform, it offers service niches in drug delivery.
TAHO’s transdermal delivery platform allows the active ingredient to be absorbed by the skin and distributed through the bloodstream. It transform the patient care by:
． Continuous delivery, safe, reliable, and pain-free application
． Improved convenience, tolerability, and dosing
． Flexible drug administration
TAHO’s transmucosal delivery system, delivery the drug as a thin film, an evolution from tablets or capsules. It is a better patient care with:
． Convenient dosing, no water needed
． No risk of choking
． Taste masking
Let TAHO be your partner for innovative solutions and diverse your product pipeline
From the publishers of Nature, the BioPharma Dealmakers website brings together life sciences companies and individuals looking to identify and attract partners and dealmaking opportunities. It provides insights into dealmaking trends from BioPharma Dealmakers Editors, profiles from companies looking to partner, tools for networking and sharing knowledge, and the opportunity for sponsoring companies to showcase their expertise. BioPharma Dealmakers is THE destination for partnering professionals looking to make connections and get the latest on their industry.